Question 1

What is the share price of Emcure Pharmaceuticals Ltd today?

Accepted Answer

Emcure Pharmaceuticals Ltd (EMCURE) is trading at ₹1,770.4. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is EMCURE’s P/E ratio versus the sector?

Accepted Answer

EMCURE trades at a P/E of 42.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is EMCURE’s dividend yield?

Accepted Answer

EMCURE has a dividend yield of 0.19%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is EMCURE’s 52-week high and low?

Accepted Answer

EMCURE has traded between ₹1,306.5 and ₹2,100.7 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Emcure Pharmaceuticals Ltd?

Accepted Answer

Emcure Pharmaceuticals Ltd has a market capitalisation of ₹35,404 crore.

Question 6

What is EMCURE’s return on equity?

Accepted Answer

EMCURE reports a return on equity of 22.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.

Question 7

Who are EMCURE’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is EMCURE’s promoter holding?

Accepted Answer

Promoters hold 77.83% of EMCURE. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include EMCURE?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight EMCURE carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Emcure Pharmaceuticals Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from EMCURE’s own numbers. The judgement is yours.

Revenue	₹5,243 crore
Net profit	₹733 crore
Operating margin	20%
EPS	₹38.66

EMCURE

EMCURE

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

EMCURE financial summary